TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegeneration

In-Vitro Score: 0.850 Price: $0.50 Neurodegeneration (AD/PD) iPSC-derived microglia-astrocyte-neuron triple co-culture Status: proposed

What This Experiment Tests

In-Vitro experiment designed to assess clinical efficacy targeting N/A in iPSC-derived microglia-astrocyte-neuron triple co-culture. Primary outcome: Astrocyte neuroprotective marker panel and neuron survival under oxidative stress

Description

Elucidate the molecular mechanisms by which TREM2 expressed on microglia mediates beneficial cross-talk with astrocytes, and how this axis is disrupted in TREM2 deficiency models of neurodegeneration.

TARGET GENE
N/A
MODEL SYSTEM
iPSC-derived microglia-astrocyte-neuron triple co-culture
ESTIMATED COST
$40,000
TIMELINE
9 months
PATHWAY
N/A
SOURCE
auto-generated
PRIMARY OUTCOME
Astrocyte neuroprotective marker panel and neuron survival under oxidative stress

Scoring Dimensions

Info Gain 0.82 (25%) Feasibility 0.78 (20%) Hyp Coverage 0.88 (20%) Cost Effect. 0.75 (15%) Novelty 0.80 (10%) Ethical Safety 0.00 (10%) 0.850 composite

Protocol

in-vitro

Expected Outcomes

TREM2 knockdown in microglia reduces astrocyte activation toward neuroprotective phenotype (reduced GFAP, increased S100A10), and co-culture supernatant is less protective against oxidative stress injury.

Success Criteria

Astrocyte phenotype markers (RT-qPCR, ELISA: GFAP, S100A10, IL-10); neuron survival after oxidative stress (MTT/WST-8); threshold: p < 0.05.

Related Hypotheses (0)

No related hypotheses

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.